{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:22:53Z","timestamp":1769282573850,"version":"3.49.0"},"reference-count":5,"publisher":"Societas Neurologica Japonica","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2014]]},"DOI":"10.5692\/clinicalneurol.54.975","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T04:17:11Z","timestamp":1418962631000},"page":"975-977","source":"Crossref","is-referenced-by-count":1,"title":["A novel therapeutic target in neuromyelitis optica and multiple sclerosis: high mobility group box 1 (HMGB1)"],"prefix":"10.5692","volume":"54","author":[{"given":"Masahiro","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Wang H, Ward MF, Sama AE. Targeting HMGB1 in the treatment of sepsis. Expert Opin Ther Targets 2014;18:257-268.","DOI":"10.1517\/14728222.2014.863876"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Liu K, Mori S, Takahashi HK, et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J 2007;21:3904-3916.","DOI":"10.1096\/fj.07-8770com"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Zhang J, Takahashi HK, Liu K, et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011;42:1420-1408.","DOI":"10.1161\/STROKEAHA.110.598334"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Uzawa A, Mori M, Masuda S, et al. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2013;84:517-522.","DOI":"10.1136\/jnnp-2012-304039"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Uzawa A, Mori M, Taniguchi J, et al. Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis. Clin Exp Immunol 2013;172:37-43.","DOI":"10.1111\/cei.12036"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u8996\u795e\u7d4c\u810a\u9ac4\u708e\u3068\u591a\u767a\u6027\u786c\u5316\u75c7\u306e\u65b0\u305f\u306a\u6cbb\u7642\u6a19\u7684\uff1ahigh mobility group box 1\uff08HMGB1\uff09"],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T22:20:06Z","timestamp":1498170006000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/54.975?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.54.975","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}